dr michael murray neuropathy acetyl l carnitine T. Murray, ND Research Opportunities - St. George's
Description
Y., Akhter, Md
In China, ALC is undergoing phase III clinical trials as a medication to alleviate paresthesia caused by diabetic peripheral neuropathy (17)
Heart rate, intervals and wave amplitudes (N = 8, 12, 14, 8)
This is a relevant approach since corneal injury leads to opacification as a consequence of TGF-induced TRPV1 upregulation followed by increases in keratocyte transdifferentiation into myofibroblasts
